Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes management.

Liraglutide, a medication commonly used to treat diabetes, has shown promising results in reducing chronic migraine in ...

The increasing prevalence of overweight and obesity in China poses an urgent public health challenge requiring immediate ...

A novel oral peptide PN-477o with once-daily dosing, high potency and activation of glucagon-like peptide-1 (GLP-1), ...

A new study finds that the diabetes drug liraglutide significantly reduced monthly migraine days in patients with obesity and ...

A common diabetes drug may be the next big thing for migraine relief. In a clinical study, obese patients with chronic ...

A GLP-1 medication used to treat type 2 diabetes and obesity may help cut a person's monthly migraine days by about half, a ...

What is Ozempic teeth? Here is what you need to know about how the weight loss drug Ozempic may be impacting your health.

A diabetes medication that lowers brain fluid pressure has cut monthly migraine days by more than half, according to a new ...

GLP-1RA use necessitated shifting priorities in nutrition and lifestyle modification among patients with obesity, according ...

China NMPA approves Innovent’s mazdutide, first dual GCG/GLP-1 receptor agonist for chronic weight management: San Francisco, US Monday, June 30, 2025, 12:00 Hrs [IST] Innovent ...